These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11090840)

  • 1. Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart.
    Du XJ; Gao XM; Wang B; Jennings GL; Woodcock EA; Dart AM
    Cardiovasc Res; 2000 Dec; 48(3):448-54. PubMed ID: 11090840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression.
    Gao XM; Agrotis A; Autelitano DJ; Percy E; Woodcock EA; Jennings GL; Dart AM; Du XJ
    Endocrinology; 2003 Sep; 144(9):4097-105. PubMed ID: 12933684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis.
    Du XJ; Autelitano DJ; Dilley RJ; Wang B; Dart AM; Woodcock EA
    Circulation; 2000 Jan 4-11; 101(1):71-7. PubMed ID: 10618307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
    Xu Q; Dalic A; Fang L; Kiriazis H; Ritchie RH; Sim K; Gao XM; Drummond G; Sarwar M; Zhang YY; Dart AM; Du XJ
    Br J Pharmacol; 2011 Mar; 162(5):1012-28. PubMed ID: 20955367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors.
    Du XJ; Gao XM; Jennings GL; Dart AM; Woodcock EA
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2456-63. PubMed ID: 11045983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
    Yan L; Vatner SF; Vatner DE
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1521-8. PubMed ID: 25193472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
    Keller K; Maass M; Dizayee S; Leiss V; Annala S; Köth J; Seemann WK; Müller-Ehmsen J; Mohr K; Nürnberg B; Engelhardt S; Herzig S; Birnbaumer L; Matthes J
    Cardiovasc Res; 2015 Dec; 108(3):348-56. PubMed ID: 26464333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice.
    Engelhardt S; Hein L; Keller U; Klämbt K; Lohse MJ
    Circ Res; 2002 Apr; 90(7):814-9. PubMed ID: 11964375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-Specific Overexpression of Oxytocin Receptor Leads to Cardiomyopathy in Mice.
    Jung C; Wernly B; Bjursell M; Wiseman J; Admyre T; Wikström J; Palmér M; Seeliger F; Lichtenauer M; Franz M; Frick C; Andersson AK; Elg M; Pernow J; Sjöquist PO; Bohlooly-Y M; Wang QD
    J Card Fail; 2018 Jul; 24(7):470-478. PubMed ID: 29802896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.
    Nakayama H; Chen X; Baines CP; Klevitsky R; Zhang X; Zhang H; Jaleel N; Chua BH; Hewett TE; Robbins J; Houser SR; Molkentin JD
    J Clin Invest; 2007 Sep; 117(9):2431-44. PubMed ID: 17694179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice.
    Bisognano JD; Weinberger HD; Bohlmeyer TJ; Pende A; Raynolds MV; Sastravaha A; Roden R; Asano K; Blaxall BC; Wu SC; Communal C; Singh K; Colucci W; Bristow MR; Port DJ
    J Mol Cell Cardiol; 2000 May; 32(5):817-30. PubMed ID: 10775486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.
    Liggett SB; Tepe NM; Lorenz JN; Canning AM; Jantz TD; Mitarai S; Yatani A; Dorn GW
    Circulation; 2000 Apr; 101(14):1707-14. PubMed ID: 10758054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
    Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
    J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous ventricular tachyarrhythmias in β2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis.
    Nguyen MN; Kiriazis H; Ruggiero D; Gao XM; Su Y; Jian A; Han LP; McMullen JR; Du XJ
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H946-57. PubMed ID: 26116714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
    Ramratnam M; Sharma RK; D'Auria S; Lee SJ; Wang D; Huang XY; Ahmad F
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyopathy characterizing and heart failure risk predicting by echocardiography and pathoanatomy in aged male mice.
    Du XJ; Feng XH; Ming ZQ; Kiriazis H
    Physiol Rep; 2024 Oct; 12(20):e70061. PubMed ID: 39411804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.